GlassScriptPhysician profile
Scott Fuchs
NPI 1982803284
$5,563.33
in general payments reported to CMS, 2019-2025
38 companies · $1,340 in 2025
The $1,340 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $983 · 2020: $197 · 2021: $485 · 2022: $396 · 2023: $1,125 · 2024: $1,038 · 2025: $1,340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,502.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,346.73 | 2022-2025 | Intracept, General - Therapies, General - Pain Management |
| Nevro Corp. | $622.50 | 2019-2024 | Senza |
| Abbott Laboratories | $467.45 | 2019-2024 | Proclaim, Eterna |
| Collegium Pharmaceutical, INC. | $438.82 | 2019-2025 | Belbuca, Xtampza |
| Abbvie INC. | $430.29 | 2021-2025 | |
| Medtronic, INC. | $293.46 | 2024-2025 | Intellis Adaptivestim |
| Spinal Simplicity, LLC | $262.92 | 2023-2025 | Ha Minuteman G3-R |
| Vertos Medical, INC. | $171.81 | 2023 | Mild Device Kit |
| Relievant Medsystems, INC. | $139.96 | 2023 | Intracept |
| Scilex Pharmaceuticals INC. | $137.73 | 2019-2022 | |
| Painteq LLC | $129.13 | 2024 | Painteq |
| Radius Health, INC. | $113.89 | 2021-2024 | Tymlos |
| Allergan, INC. | $100.77 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $91.80 | 2025 | |
| Pfizer INC. | $85.91 | 2019-2024 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Fuchs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.